ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

FACE Physicians Formula Holdings, Inc. (MM)

4.90
0.00 (0.00%)
15 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Physicians Formula Holdings, Inc. (MM) NASDAQ:FACE NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 4.90 0 01:00:00

- Current report filing (8-K)

27/05/2011 6:28pm

Edgar (US Regulatory)


 


 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
 
FORM 8-K
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): May 24, 2011
 
PHYSICIANS FORMULA HOLDINGS, INC.
(Exact name of registrant as specified in its charter)
 
Delaware
(State or other jurisdiction of incorporation)
 
001-33142
(Commission File Number)
 
23-0340099
(IRS Employer Identification No.)
 
1055 West 8 th Street
Azusa, California 91702
(Address of principal executive offices, including Zip Code)
 
(626) 334-3395
(Registrant’s telephone number, including area code)
 
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[  ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[  ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[  ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[  ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 


 
 

 

Item 5.02.  Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
 
     On May 24, 2011, Mr. Padraic Spence, a director since April 2009, resigned as a director from the Board of Directors of Physicians Formula Holdings, Inc. (the Company ) in order to pursue other business and personal interests. Mr. Spence s decision is not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices. The Nominating and Corporate Governance Committee is proceeding with plans to recruit a successor to Mr. Spence.
 
 
-2-

 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
PHYSICIANS FORMULA HOLDINGS, INC.
 
 
 
 
 
Date: May 27, 2011
By:
/s/ Jeff Berry
 
 
 
Name: Jeff Berry
 
 
 
Title:   Chief Financial Officer
 
 
 
 
 


 
-3-

 

1 Year Physicians Formula Holdings, Inc. (MM) Chart

1 Year Physicians Formula Holdings, Inc. (MM) Chart

1 Month Physicians Formula Holdings, Inc. (MM) Chart

1 Month Physicians Formula Holdings, Inc. (MM) Chart

Your Recent History

Delayed Upgrade Clock